Yet another city in California is taking steps to pass a resolution aimed at decriminalizing psychedelics. This comes after a council member from Arcata City, California, agreed to spearhead the reform effort.
Last week Decriminalize Nature Humboldt revealed that Sarah Schaefer, a councilmember, had accepted the lead in championing a resolution as it makes its way through the council. Schaefer agreed to support the resolution until there is a policy change that makes the enforcement of laws against entheogenic substances, such as ibogaine and psilocybin mushrooms, the lowest priority for law enforcement agencies. In addition, the group announced that during next month, it will be discussing this important measure with different city lawmakers in order to galvanize support for the initiative.
In a press release, Schaefer stated that the resolution was consistent with what many Arcatans believed and that by decriminalizing these fungi and plants, the city would take a big step towards dismantling the failed drug war. The move would also make it possible for researchers to study the potential therapeutic benefits of those substances, she added.
Taylor Albanmonti, a member of the Humboldt chapter of Decriminalize Nature, explained that psychedelic fungi and plants provide a pathway through which individuals afflicted by treatment resistant psychiatric conditions can find healing. He adds that the right of everyone to nurture a relationship with the sacred plants mentioned in the resolution shouldn’t be curtailed, and that equitable access to these medicines shouldn’t be blocked by draconian laws.
If this resolution is approved, Arcata will follow in the footsteps of Santa Cruz and Oakland, which both passed similar resolutions in the recent past.
Meanwhile, a bill to legalize some psychedelics is making its way through the state legislature as well. That bill was approved by the state Senate and is now weaving through different committees of the Assembly in California.
In similar action across the country, the movement to enact psychedelic policy reform has seen a trio of Massachusetts cities — Somerville, Cambridge and Northampton — decriminalize psychedelic substances. Attempts are also underway to decriminalize psychedelics as well as other drugs that are currently outlawed. For example, Texas recently passed a bill requiring the state to conduct studies aimed at establishing whether psychedelics can be therapeutically beneficial to military veterans.
Further evidence of the psychedelics reform movement’s success are the research centers established at leading academic institutions, including Johns Hopkins University. Harvard Law School has also established a psychedelics policy research center, a first in the country.
The work of these academic institutions and jurisdictions changing their psychedelics laws is likely to spread awareness about the potential remedies that companies such as XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) are working to develop.
NOTE TO INVESTORS: The latest news and updates relating to XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) are available in the company’s newsroom at https://ibn.fm/XPHYF
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com
InvestorWire is part of the InvestorBrandNetwork.